Virpax Pharmaceuticals Inc VRPX:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
5.64quote price arrow up+0.13 (+2.27%)
Volume
25,388
52 week range
5.25 - 8.24

...

Loading . . .

KEY STATS

  • Open5.63
  • Day High5.69
  • Day Low5.51
  • Prev Close5.51
  • 52 Week High8.24
  • 52 Week High Date02/17/21
  • 52 Week Low5.25
  • 52 Week Low Date02/26/21
  • Market Cap25.41M
  • Shares Out4.51M
  • 10 Day Average Volume0.37M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.21
  • P/E (TTM)-26.51
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-3.509M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-56.12%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Virpax Pharmaceuticals Inc News

There is no recent news for this security.

Latest VRPX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Virpax Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing pharmaceutical product candidates for pain management by developing and delivering non-opioid and non-addictive pharmaceutical products. Its products include Epoladerm, OSF200, Probudur, NES100, PES200 and MMS019. Epoladermis is developed as a topical nonsteroidal anti-inflammatory drug (NSAID) treatment for acute pain. OSF200 utilizes the same transdermal delivery system as...
Address
1554 Paoli Pike #279, #279
West Chester, PA
19380
United States